Logo image of CWEB.CA

CHARLOTTES WEB HOLDINGS INC (CWEB.CA) Stock Fundamental Analysis

TSX:CWEB - Toronto Stock Exchange - CA16106R1091 - Common Stock - Currency: CAD

0.14  0 (0%)

Fundamental Rating

1

Taking everything into account, CWEB scores 1 out of 10 in our fundamental rating. CWEB was compared to 35 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CWEB have multiple concerns. CWEB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CWEB had negative earnings in the past year.
In the past year CWEB has reported a negative cash flow from operations.
In the past 5 years CWEB always reported negative net income.
In the past 5 years CWEB always reported negative operating cash flow.
CWEB.CA Yearly Net Income VS EBIT VS OCF VS FCFCWEB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

The Return On Assets of CWEB (-29.31%) is worse than 70.59% of its industry peers.
CWEB has a Return On Equity of -115.94%. This is in the lower half of the industry: CWEB underperforms 70.59% of its industry peers.
Industry RankSector Rank
ROA -29.31%
ROE -115.94%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWEB.CA Yearly ROA, ROE, ROICCWEB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

1.3 Margins

CWEB's Gross Margin of 47.25% is in line compared to the rest of the industry. CWEB outperforms 58.82% of its industry peers.
In the last couple of years the Gross Margin of CWEB has declined.
CWEB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y-5.7%
CWEB.CA Yearly Profit, Operating, Gross MarginsCWEB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

CWEB does not have a ROIC to compare to the WACC, probably because it is not profitable.
CWEB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CWEB.CA Yearly Shares OutstandingCWEB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
CWEB.CA Yearly Total Debt VS Total AssetsCWEB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

CWEB has an Altman-Z score of -3.61. This is a bad value and indicates that CWEB is not financially healthy and even has some risk of bankruptcy.
CWEB has a worse Altman-Z score (-3.61) than 64.71% of its industry peers.
CWEB has a Debt/Equity ratio of 1.49. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.49, CWEB is doing worse than 82.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Altman-Z -3.61
ROIC/WACCN/A
WACC8.53%
CWEB.CA Yearly LT Debt VS Equity VS FCFCWEB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

A Current Ratio of 3.03 indicates that CWEB has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.03, CWEB is doing good in the industry, outperforming 79.41% of the companies in the same industry.
A Quick Ratio of 1.85 indicates that CWEB should not have too much problems paying its short term obligations.
CWEB has a Quick ratio of 1.85. This is in the better half of the industry: CWEB outperforms 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.85
CWEB.CA Yearly Current Assets VS Current LiabilitesCWEB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M

More info and screens

1

3. Growth

3.1 Past

CWEB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.94%, which is quite impressive.
CWEB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.15%.
The Revenue has been decreasing by -1.90% on average over the past years.
EPS 1Y (TTM)31.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-20.15%
Revenue growth 3Y-12.79%
Revenue growth 5Y-1.9%
Sales Q2Q%-11.98%

3.2 Future

CWEB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.31% yearly.
Based on estimates for the next years, CWEB will show a very negative growth in Revenue. The Revenue will decrease by -12.35% on average per year.
EPS Next Y15%
EPS Next 2Y20.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.8%
Revenue Next 2Y-12.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CWEB.CA Yearly Revenue VS EstimatesCWEB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CWEB.CA Yearly EPS VS EstimatesCWEB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CWEB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CWEB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CWEB.CA Price Earnings VS Forward Price EarningsCWEB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWEB.CA Per share dataCWEB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as CWEB's earnings are expected to grow with 20.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.31%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CWEB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHARLOTTES WEB HOLDINGS INC

TSX:CWEB (2/21/2025, 7:00:00 PM)

0.14

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)03-03 2025-03-03/amc
Inst Owners2.28%
Inst Owner ChangeN/A
Ins Owners9.62%
Ins Owner ChangeN/A
Market Cap22.12M
Analysts82.86
Price Target0.51 (264.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.65%
Min EPS beat(2)-37.25%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)-4.34%
Min EPS beat(4)-37.25%
Max EPS beat(4)15.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.6%
Min Revenue beat(2)-10.23%
Max Revenue beat(2)-4.98%
Revenue beat(4)0
Avg Revenue beat(4)-17.11%
Min Revenue beat(4)-36.34%
Max Revenue beat(4)-4.98%
Revenue beat(8)0
Avg Revenue beat(8)-16.62%
Revenue beat(12)0
Avg Revenue beat(12)-17.72%
Revenue beat(16)0
Avg Revenue beat(16)-16.8%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 1.09
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.47
BVpS0.27
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.31%
ROE -115.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.25%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y-5.7%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.57%
Cap/Sales 8.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.03
Quick Ratio 1.85
Altman-Z -3.61
F-Score4
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)23.99%
Cap/Depr(5y)172.72%
Cap/Sales(3y)3.78%
Cap/Sales(5y)11.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y15%
EPS Next 2Y20.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.15%
Revenue growth 3Y-12.79%
Revenue growth 5Y-1.9%
Sales Q2Q%-11.98%
Revenue Next Year-28.8%
Revenue Next 2Y-12.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.43%
EBIT Next 3Y19.65%
EBIT Next 5YN/A
FCF growth 1Y-160.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-148.93%
OCF growth 3YN/A
OCF growth 5YN/A